Bowel Polyps & Cancer Risk: 5x Higher with Combined Types – Study
A new study from Flinders University and Flinders Medical Centre has revealed a significantly increased risk of bowel cancer for individuals with both adenomatous polyps and serrated polyps – a combination researchers are calling “synchronous lesions.” The findings, published in the journal Clinical Gastroenterology and Hepatology, suggest that the presence of both polyp types can raise the risk of advanced precancerous changes by up to fivefold compared to those with only one type.
Bowel cancer, also known as colorectal cancer, remains a substantial public health challenge in Australia, ranking as the second leading cause of cancer death and the fourth most frequently diagnosed cancer. Understanding the nuances of polyp development and risk stratification is crucial for effective prevention and early detection.
The Dual Pathway to Bowel Cancer
Polyps, growths on the inner lining of the bowel, are common and often benign. However, adenomas and serrated polyps are recognized as precursors to colorectal cancer. The Flinders University research highlights that the simultaneous presence of these two polyp types isn’t simply additive in terms of risk; it represents a potentially distinct and more aggressive pathway to cancer development.
“Polyps are common and usually harmless, but when both types appear together — what we call synchronous lesions — the risk of serious bowel disease or cancer rises sharply,” explains Dr. Molla Wassie, lead author and researcher at the FHMRI Bowel Health Service. The study analyzed colonoscopy records of over 8,400 patients, revealing that nearly half of those diagnosed with serrated polyps also had adenomas.
What Makes This Combination So Risky?
The researchers propose that adenomas and serrated polyps may develop through separate, yet concurrent, cancer pathways. This concept aligns with growing international evidence suggesting a more complex understanding of colorectal cancer development than previously thought. The study supports the idea that these pathways can be active at the same time, emphasizing the importance of comprehensive screening and monitoring.
Serrated polyps, in particular, are gaining attention for their potential to progress to cancer more rapidly than adenomas. This finding underscores the necessitate for tailored screening strategies and follow-up colonoscopy schedules that account for the specific type of polyp identified. The National Bowel Cancer Screening Program (https://www.cancer.org.au/cancer-types/bowel-cancer/screening) offers valuable information on available screening options.
Understanding Polyp Types: Adenomas vs. Serrated Polyps
Adenomas are the most common type of polyp and are generally considered to have a slower progression to cancer. They are often detected and removed during routine colonoscopies. Serrated polyps, have a more subtle appearance and can be more challenging to identify. Their potential for rapid progression makes their detection and removal particularly critical.
The distinction between these polyp types is important because it influences the recommended surveillance intervals after removal. Current guidelines, such as those from the American Cancer Society (https://www.cancer.org/cancer/types/colorectal-cancer/detection-diagnosis-staging/signs-and-symptoms.html), typically recommend shorter intervals for follow-up colonoscopies after the removal of serrated polyps, especially when found in combination with adenomas.
The Importance of Regular Screening
“Polyps become more common as we age, but the key is catching and removing them early,” Dr. Wassie emphasizes. “If you’ve had both types of polyps, it’s especially important to stay on top of your colonoscopy schedule.”
Individuals over the age of 45, or those with a family history of bowel cancer or polyps, are strongly encouraged to discuss screening options with their general practitioner. The SCOOP program, the Southern Cooperative Program for the Prevention of Colorectal Cancer, is one initiative aimed at improving bowel cancer prevention rates in Australia. Flinders Medical Centre plays a key role in community-based programs designed to improve gut and liver health, offering assistance to GPs and support for patients (https://www.sahealth.sa.gov.au/wps/wcm/connect/Public%20Content/SA%20Health%20Internet/Services/Hospitals/Flinders%20Medical%20Centre/Services%20and%20clinics%20at%20Flinders%20Medical%20Centre/Services%20at%20Flinders%20Medical%20Centre/Gastroenterology%20and%20Hepatology%20Services%20at%20Flinders%20Medical%20Centre).
What Does This Mean for Future Screening Strategies?
The Flinders University study adds weight to the argument for refining colorectal cancer screening strategies. Whereas current guidelines are effective, the identification of this increased risk associated with synchronous lesions suggests a need for more personalized approaches. This could involve incorporating more detailed polyp characterization during colonoscopy and tailoring follow-up intervals based on the specific combination of polyp types found.
Further research is needed to fully understand the underlying mechanisms driving the development of these dual pathways and to identify individuals who may benefit most from more intensive screening. The research team at Flinders Medical Centre continues to investigate these questions, supported by grants such as the NHMRC Investigator Grant (#2009050) awarded to Dr. Wassie. The Gastroenterology Clinic at Flinders Medical Centre offers consultation, procedures, and therapeutic services for a range of gastrointestinal conditions, including those related to polyp detection and management (https://www.healthdirect.gov.au/australian-health-services/healthcare-service/bedford-park-5042-sa/flinders-medical-centre-upper-gastrointestinal-cancer-clinical-practice/gastroenterology/64cbb0ad-f391-7072-a3cc-cdf82767db2b).
Looking Ahead: Ongoing surveillance and research efforts will be crucial to refine our understanding of colorectal cancer risk and to optimize screening strategies for the benefit of all Australians.